Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-16-029577
Filing Date
2016-09-12
Accepted
2016-09-12 19:14:52
Documents
2
Period of Report
2016-09-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2257
2 ex24couturier.txt EX-24 3856
  Complete submission text file 0001179110-16-029577.txt   7513
Mailing Address 9 FOURTH AVE WALTHAM MA 02451
Business Address 9 FOURTH AVE WALTHAM MA 02451 617-500-2802
OvaScience, Inc. (Issuer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9 FOURTH AVENUE C/O OVASCIENCE INC. CAMBRIDGE MA 02451
Business Address
Couturier Christophe (Reporting) CIK: 0001684076 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35890 | Film No.: 161881809